PURE BIOSCIENCE, INC. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pure Bioscience, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2024.
  • Pure Bioscience, Inc. Share-based Payment Arrangement, Expense for the quarter ending October 31, 2023 was $80K, a 27% increase year-over-year.
  • Pure Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $214K, a 18.3% decline from 2023.
  • Pure Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $262K.
  • Pure Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $758K, a 36.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $214K -$48K -18.3% Aug 1, 2023 Jul 31, 2024 10-K 2024-10-29
2023 $262K Aug 1, 2022 Jul 31, 2023 10-K 2024-10-29
2021 $758K +$203K +36.6% Aug 1, 2020 Jul 31, 2021 10-K 2021-10-28
2020 $555K -$832K -60% Aug 1, 2019 Jul 31, 2020 10-K 2020-10-08
2019 $1.39M -$138K -9.05% Aug 1, 2018 Jul 31, 2019 10-K 2020-10-08
2018 $1.53M Aug 1, 2017 Jul 31, 2018 10-K 2019-10-30
2016 $1.9M -$480K -20.2% Aug 1, 2015 Jul 31, 2016 10-K 2016-10-27
2015 $2.38M -$576K -19.5% Aug 1, 2014 Jul 31, 2015 10-K 2016-10-27
2014 $2.96M +$2.24M +311% Aug 1, 2013 Jul 31, 2014 10-K 2015-10-28
2013 $720K Aug 1, 2012 Jul 31, 2013 10-K 2014-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.